Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza

Vanderven HA., Wentworth DN., Han WM., Peck H., Barr IG., Davey, Jr. RT., Beigel JH., Dwyer DE., Jain MK., Angus B., Brandt CT., Mykietiuk A., Law MG., Neaton JD., Kent SJ.

DOI

10.1172/jci.insight.167464

Type

Journal

JCI Insight

Publisher

American Society for Clinical Investigation

Publication Date

08/06/2023

Permalink Original publication